Serum institute to price Covid-19 dose at $3 per dose for low income nations

Serum Institute of India (SII), the world’s biggest vaccine manufacturer by means of extent has capped the prize of Covid-19 vaccine at $3 per dose for low and middle earnings nations, such as India as part of a brand new partnership with Gavi, The Vaccine Alliance, and the Bill & Melinda Gates Foundation.

SII will manufacture and deliver up to 100 million doses of the below development AstraZeneca/Oxford and Novavax COVID-19 vaccines for India and 92 other low- and center-income international locations (LMICs) that, company said in an assertion.

As part of the agreement SII may also get upfront capital of $150 mn via the Bill and Melinda Gates Foundation to assist the employer increase manufacturing ability now in order that, once a vaccine, or vaccines, profits regulatory approval and WHO prequalification, doses may be produced at scale for distribution below the COVAX settlement.